Special Issue "Hepatitis Virus Infection and Research"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 March 2017).
Interests: viral hepatitis; hepatocellular carcinoma, innate immunity; unfolded protein response
Special Issues, Collections and Topics in MDPI journals
Special Issue in Diseases: Hepatitis and Treatment
Special Issue in International Journal of Molecular Sciences: Hepatitis Virus Infection and Molecular Research 2018
Special Issue in International Journal of Molecular Sciences: Molecular Mechanisms, Diagnosis and Treatments in Digestive Malignancy
Special Issue in International Journal of Molecular Sciences: Hepatitis Virus Infection and Molecular Research 2021
Special Issue in Cancers: Liver Cancer: Improving Standard Diagnosis and Therapy
Topics: Liver Fibrosis and Cirrhosis
Welcome to this Special Issue, “Hepatitis Virus Infection and Research”, of the International Journal of Molecular Sciences. Infections of hepatitis A virus (HAV), HBV, HCV, HDV, and HEV are still a serious issue worldwide, although effective vaccines for HAV and HBV have been developed. HAV and HBV are major causes of acute hepatitis, including acute hepatic failure (ALF). The mechanism of hepatocarcinogenesis in HBV and HCV infections is still unclear. Effective interferon-free treatment against HCV is now available, but it has led to several problems, such as the occurrence of hepatocellular carcinoma (HCC) after sustained virological response, non-response to direct-acting antivirals, and treatment of decompensated cirrhosis. HEV causes ALF, but the root of HEV infection is still unclear in certain cases and chronic HEV infection has been reported in transplant patients. Thus, taken together, it is clear that a lot of issues still exist in clinical practice and basic research areas. This Special Issue will present the latest findings related to viral hepatitis, the association with HCC, and so on. Original research and review articles on all topics in this area are invited. It is my greatest pleasure to invite research scientists and clinicians from all relevant fields to submit their articles for this Special Issue. Please accept my special thanks for choosing to publish in the International Journal of Molecular Sciences. I am looking forward to your submissions for this highly important Special Issue.
Dr. Tatsuo Kanda
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- acute hepatitis
- liver fibrosis